| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |